BOEHRINGER INGELHEIM GMBH Pricing & Demo

Are you from this Company?
BOEHRINGER INGELHEIM GMBH
Write a Review
Ingelheim, Germany
1885
$10BN to $50BN
Enterprise
92 Likes
78 Buyers Negotiating
Summary
No Summary And Details

Popular Comparisons

Discussions

Strengths
  • +14
    Products offered by the company
  • +11
    Separate brand or technology platform focused on range of veterinary vaccines products
  • +9
    Live Attenuated Vaccines
  • +13
    Marketing collaborations
  • +7
    Poultry Vaccines
  • +10
    Inactivated Vaccines
  • +6
    Livestock Vaccines
  • +12
    Research studies sponsorships/product mentions
  • +8
    Companion Vaccines
  • +11
    Toxoid Vaccines
  • +11
    Conferences/ tradeshows
  • +14
    Others strategies
  • +5
    R&D spending as a percent of revenue in FY 2016
  • +13
    Product Segment wise coverage of the product
  • +6
    Technological advancement of the product function
  • +14
    New product approvals/launches by company in last three years
  • +13
    Breadth and Depth of Product Offerings
  • +5
    Porcine Vaccines
  • +9
    Aquaculture Vaccines
  • +12
    Recombinant Vaccines
Cautions
  • -5
    Focus on Product Innovation
  • -6
    Product Branding
  • -14
    Product Features and Functionality
  • -10
    Other Vaccines
  • -13
    Other Vaccines (DNA, Subunit, Conjugate)
I agree to 360Quadrants Terms of use and privacy policy
Success
info
Error
Company Size :
  Enterprise
  SME
  Startup
logo-360
  • saved

    You haven’t saved anything yet

    To save, search for Vendors by
    Name or Category, then tap the heart